Headlines New Drugs Drug Alert EMEA FDA Health Canada MHRA NICE TGA MedSafe AZ Guide
 
 


 

Preoperative statin therapy linked to reduced cardiac mortality after CABG

Statin therapy in ambulatory populations is associated with a significant reduction in adverse cardiovascular events, including death and myocardial infarction.
Data about effects of statins on acute perioperative cardiovascular events are limited.

A study verified whether preoperative statin therapy is associated with a reduced risk of early cardiac death or nonfatal, in-hospital postoperative myocardial infarction after primary, elective coronary artery bypass graft surgery ( CABG ) requiring cardiopulmonary bypass.

The present study consisted of a pre-specified subset of patients, divided into two groups: patients receiving ( n = 1352 ) and not receiving ( n = 1314 ) preoperative statin therapy.

A total of 5436 patients, undergoing coronary artery bypass graft surgery, took part in The Multicenter Study of Perioperative Ischemia ( McSPI ) Epidemiology II Study, a prospective, longitudinal study.

Preoperative statin therapy was independently associated with a significant reduction ( adjusted odds ratio [OR] 0.25 ) in the risk of early cardiac death after primary, elective coronary bypass surgery ( 0.3% versus 1.4%; P < 0.03 ), but was not associated with a reduced risk of postoperative nonfatal, in-hospital myocardial infarction ( 7.9% versus 6.2%; P = not significant ).

Discontinuation of statin therapy after surgery was independently associated with a significant increase in late all-cause mortality ( adjusted OR 2.64 ) compared with continuation of statin therapy ( 2.64% versus 0.60%; P < 0.01 ).
Discontinuation of statin therapy after surgery was also independently associated with a significant increase in late cardiac mortality ( adjusted OR 2.95 ) compared with continuation of statin therapy ( 1.91% versus 0.45%; P < 0.01 ).

The study found that preoperative statin use is associated with reduced cardiac mortality after primary, elective coronary artery bypass grafting, and postoperative statin discontinuation is associated with increased in-hospital mortality.

These data suggest the importance of perioperative statin administration, according to authors.

Source: The Journal of Thoracic and Cardiovascular Surgery, 2006


XagenaMedicine2006


« Home | Stampa articolo | Invia E-mail
Google
Web
Xagena News

  




Annunci Google:


n Xagena.it

Powered by Luca Malattia - LM Web Solutions